Evaluate the Effects of the Environmental Change in Intestine by Antibiotics on the Pharmacokinetic Characteristics of Simvastatin in Healthy Male Volunteers
NCT03403972 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2018-01-19
Summary
This phase 1 clinical trial is to evaluate the effects of the environmental change in intestine by antibiotics on the pharmacokinetic characteristics of simvastatin in healthy male volunteers. For change of intestine environment, especially the gut microbiota, investigators will administer PO vancomycin for 7 days, tid.
Conditions
- Simvastatin Pharmacokinetics and Gut Microbiome
Interventions
- DRUG
-
Vancomycin 250Mg Capsule
Investigators will compare simavastatin pharmacokinetics before and after the vancomycin PO multiple administration.
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Principal Investigators
-
SeungHwan Lee, MD, PhD · Seoul National University Hospital
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 19 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-12-06
- Primary Completion
- 2018-01-11
- Completion
- 2018-01-11
Countries
- South Korea
Study Locations
More Related Trials
-
Effects of Phenoximethylpenicillin, Amoxicillin and Amoxicillin-clavulanic Acid on the Gut Microbiota
NCT04084106 ·Status: COMPLETED ·Phase: PHASE4
-
Primary Prophylaxis of Clostridioides Difficile Infection With Oral Vancomycin
NCT07221708 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Study of Metronidazole Delayed-Release Capsules in Comparison With Immediate-Release Tablets (Flagyl) for Safety and Pharmacokinetics
NCT07251127 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Gut Microbiome Intervention on Aging Via Oral FMT
NCT05598112 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibiotics
NCT02951702 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection
NCT03462459 ·Status: COMPLETED ·Phase: PHASE2
-
Fexinidazole (1200mg) Bioavailability Under Different Food Intake Conditions
NCT01340157 ·Status: COMPLETED ·Phase: PHASE1
-
Oral Vancomycin to Prevent Recurrent C Difficile Infection With Antibiotics
NCT03466502 ·Status: COMPLETED ·Phase: PHASE4
-
Fecal Microbiota Transplantation for Severe Clostridium Difficile Infection
NCT03427229 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea
NCT00034294 ·Status: COMPLETED ·Phase: PHASE2
-
Secondary Prevention of Clostridioides Difficile Using Vancomycin
NCT06979609 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
The Effects of Gut Micribiota Disruption on the Immune Response After Open Heart Surgery
NCT03939273 ·Status: UNKNOWN ·Phase: NA
-
Bioavailability Study of Metronidazole Capsules Under Fasting Conditions
NCT01380509 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Oral Antibiotic Treatment on C. Difficile
NCT02057198 ·Status: COMPLETED ·Phase: PHASE4
-
Gut Microbiota Changes After Fecal Microbiota Transplantation
NCT02557685 ·Status: UNKNOWN ·Phase: PHASE2
-
Lyophilized Fecal Microbiota Transplantation for Recurrent Clostridioides Difficile Infection
NCT03834038 ·Status: COMPLETED ·Phase: NA
-
Metagenomic and Metabolomic Reconstitution of Gut Microbiota After Broad Spectrum Antibiotic Therapy
NCT04171466 ·Status: COMPLETED ·Phase: NA
-
Bioavailability Study of Metronidazole Capsules Under Fed Conditions
NCT01380522 ·Status: COMPLETED ·Phase: PHASE1
-
The Impact of Food on Gut Microbiome Composition - a Clinical Trial Determining the Influence of Diet in Gut Microbiome Colonisation and Host Health
NCT05986955 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Vancomycin for the Treatment of NAAT(+)/Toxin(-) C. Difficile
NCT03827447 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study of Fecal Microbiota Transplantation in the Treatment of Antibiotic-associated Diarrhea
NCT05990972 ·Status: COMPLETED ·Phase: NA
-
Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease
NCT00384527 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea
NCT00382304 ·Status: COMPLETED ·Phase: PHASE2
-
A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections.
NCT06948461 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Impact of Probiotic Regimen on Vancomycin Resistant Enterococcus Intestinal Carriage
NCT00437580 ·Status: UNKNOWN ·Phase: PHASE4